Muntinlupa has fully immunized 72 percent of its target population with more than 600,000 total vaccines administered in the city to date.
Data from the city of Muntinlupa’s COVID-19 vaccination program (MunCoVac) showed that as of October 1, 277,940 people had been fully vaccinated, or 72% of the target population of 385,725. The total includes 1,091 people. who were vaccinated in private companies in the city.
In addition, 332,517 people received the first dose, or 86.2% of the target population, including 13,075 people who were vaccinated in private companies.
Muntinlupa’s target population of 385,725 represents 70% of the city’s estimated total population in 2020, or 551,036.
MunCoVac said that as of October 1, 606,098 vaccines had been administered in the city, an increase of 19,685 from the 586,413 recorded on September 24.
The city government of Muntinlupa also registers young people aged 12 to 17 for vaccination. As of September 27, 10,760 minors aged 12 to 17 have registered with MunCovac, or 19% of the total population of 55,391 for the age group.
The Inter-Agency Working Group (IATF) for the Management of Emerging Infectious Diseases published resolution No. 141 on the vaccination of the general public and minors on September 30.
“On the directives of President Rodrigo Roa Duterte, the national COVID-19 vaccination program will be open to the general public at the national level by decision of the National Working Group against COVID-19 and its vaccination group”, did he declare.
He added: “In addition, from October 16, 2021, the vaccination of the pediatric population (those aged twelve to seventeen (12-17) years) with vaccines licensed for use of Emergency by the Food and Drugs Administration will be piloted under a phased approach that can be determined by the National Center for Immunization Operations.
Presidential spokesman Secretary Harry Roque Jr. said pediatric vaccination for 12 to 17 year olds will begin with children with co-morbidities, according to the Department of Health.
He said children with comorbidities will be placed in priority group A3 and their vaccination will require the informed consent of parents or guardians and the vaccinee.
The Philippine Food and Drug Administration (FDA) has approved the Pfizer-BioNTech and Moderna vaccines for use in children ages 12 to 17.
SUBSCRIBE TO THE DAILY NEWSLETTER
CLICK HERE TO JOIN